Qian Mengao, Yin Shangyu, Hu Kepeng, Wang Quanpeng, Cao Weilan, Liu Changbao, Wang Zhonglin, Huang Chongjie
The Second School of Medicine, Wenzhou Medical University, Wenzhou, China.
Department of Colorectal Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Wideochir Inne Tech Maloinwazyjne. 2022 Sep;17(3):498-505. doi: 10.5114/wiitm.2022.116284. Epub 2022 May 13.
Natural orifice specimen extraction surgery (NOSES) has been widely regarded as a new technology in minimally invasive surgery. Meanwhile, carbon nanoparticles have been increasingly used for lymph node tracing in colorectal cancer surgery.
To evaluate the effectiveness and feasibility of carbon nanoparticle-assisted natural orifice specimen extraction surgery with left colic artery preservation for total laparoscopic colorectal resection.
We retrospectively reviewed the medical records of 83 patients diagnosed with sigmoid colon cancer or mid- and upper-rectal cancer from October 2017 to June 2020. These patients were divided into the NOSES group who underwent left colic artery preservation NOSES, being injected with a carbon nanoparticle suspension under colonoscopy the day before surgery, and the LA group, who underwent left colic artery preservation laparoscopic surgery. Surgical outcomes were retrospectively analyzed.
The mean number of harvested lymph nodes (p < 0.001) in the NOSES group was higher than in the LA group. Conversely, as regards pain score (p < 0.001) and postoperative hospital stay (p = 0.035), the LA group has higher mean values. The incidence of perioperative complications (p = 0.385) was 5.3% for the NOSES group compared to 13.3% for the LA group.
Preoperative colonoscopic injection of a carbon nanoparticle suspension is a feasible and practical solution to dissect lymph nodes surrounding the inferior mesenteric artery without affecting the left colic artery in patients with colorectal cancer and about to receive NOSES. Moreover, NOSES combined with this approach leads to less postoperative pain and shorter hospital stays.
自然腔道标本取出手术(NOSES)已被广泛视为微创手术中的一项新技术。与此同时,碳纳米颗粒在结直肠癌手术的淋巴结示踪中应用越来越多。
评估碳纳米颗粒辅助下保留左结肠动脉的自然腔道标本取出手术用于全腹腔镜结直肠癌切除术的有效性和可行性。
我们回顾性分析了2017年10月至2020年6月期间83例诊断为乙状结肠癌或中高位直肠癌患者的病历。这些患者被分为NOSES组,即接受保留左结肠动脉的NOSES手术,术前一天在结肠镜检查时注射碳纳米颗粒混悬液,以及LA组,即接受保留左结肠动脉的腹腔镜手术。对手术结果进行回顾性分析。
NOSES组平均清扫淋巴结数目高于LA组(p<0.001)。相反,在疼痛评分(p<0.001)和术后住院时间方面(p = 0.035),LA组的平均值更高。NOSES组围手术期并发症发生率为5.3%,而LA组为13.3%(p = 0.385)。
术前结肠镜下注射碳纳米颗粒混悬液对于即将接受NOSES手术的结直肠癌患者是一种可行且实用的方法,可在不影响左结肠动脉的情况下清扫肠系膜下动脉周围的淋巴结。此外,NOSES联合该方法可减轻术后疼痛并缩短住院时间。